7807.T
The company operates in the healthcare sector, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and service of medical devices and related products.
Business. The company operates in the healthcare sector, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and service of medical devices and related products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare sector, specializing in medical equipment, supplies, and distribution, generating revenue primarily through the sale and service of medical devices and related products.
The company maintains a strong liquidity position, with a current ratio of 3.12, indicating that it has more than three times the current assets to cover its current liabilities. Its cash and equivalents amount to 1,331,473,000 JPY, which is a significant portion of its total assets, further supporting its liquidity. The company's debt-to-equity ratio is 0.06, suggesting a conservative capital structure with minimal reliance on debt financing.
In terms of profitability, the company's return on equity (ROE) is 12.48%, which is a strong indicator of its ability to generate returns for shareholders. Its return on assets (ROA) is 8.42%, reflecting efficient use of its assets to generate profit. These metrics are in line with the industry's preferred metrics, which emphasize asset efficiency and return generation.
The company's revenue is concentrated in the healthcare services and equipment segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to specific market risks, particularly in the Japanese market, where it is primarily listed and operates.
The company's growth trajectory is positive, with a strong operating income of 747,215,000 JPY and a net income of 427,358,000 JPY. The outlook for the current fiscal year is favorable, with no immediate filing-based liquidity or dilution flags detected. The company's capital expenditure of -90,031,000 JPY indicates a reduction in investment, which may be a strategic move to preserve cash.
The company's risk assessment indicates a low level of liquidity and dilution risk. There are no immediate filing-based liquidity or dilution flags, and the company's conservative capital structure further supports this assessment. The company's dilution potential is low, and no significant dilution sources were identified in the recent filings.
Recent events, as reflected in the financial data, show a stable performance with a last actual EPS of 102.96 JPY and a last actual revenue of 6,394,410,000 JPY. These figures align with the company's historical performance and indicate a consistent revenue stream and profitability.
- The company has a strong liquidity position with a current ratio of 3.12 and significant cash reserves.
- It maintains a conservative capital structure with a low debt-to-equity ratio of 0.06.
- The company's profitability is robust, with a return on equity of 12.48% and a return on assets of 8.42%.
- The company's growth trajectory is positive, with a strong operating income and net income.
- The company's risk profile is low, with no immediate liquidity or dilution flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 7807.T Market data — financials · 2026-05-27
- Kowa Co Ltd Market data — analyst estimates · 2026-05-27